Oshi Health, a Rosenman Institute 2020 ADAPT Awardee, announced the successful close of a $60M Series C funding round. Oshi Health offers a reimagined approach to digestive healthcare, revolutionizing care accessibility, patient experiences, clinical results, and healthcare costs. In a personalized virtual care delivery model, Oshi Health provides diagnosis and integrated care for digestive conditions and empowers people to achieve lasting control of their symptoms.
From the press release:
Earlier this year, Oshi Health, a leader in virtual digestive care, announced the close of a $60M Series C funding round. The round was led by Oak HC/FT, with existing investors like Bessemer Venture Partners and CVS Health Ventures joining in. As a virtual gastrointestinal (GI) center of excellence, Oshi Health is revolutionizing digestive care by providing accessible, whole-person support that brings relief faster and reduces healthcare costs.
The new capital will allow Oshi to expand its services, partner with more GI practices, and bring innovative digestive care to Medicare populations in 2025. With partnerships including employers like Koch and Dayforce, Oshi’s platform reaches over 40 million people across all 50 states, empowering patients to take control of their digestive health with 24/7 support. Oshi’s unique model includes unlimited virtual visits, helping patients understand their symptoms and access ongoing care until they find lasting solutions.